250 filings
8-K
TTNP
Titan Pharmaceuticals, Inc. (de)
3 Apr 24
Entry into a Material Definitive Agreement
5:08pm
8-K
TTNP
Titan Pharmaceuticals, Inc. (de)
1 Apr 24
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:03pm
8-K
TTNP
Titan Pharmaceuticals, Inc. (de)
21 Mar 24
Unregistered Sales of Equity Securities
12:19pm
8-K
TTNP
Titan Pharmaceuticals, Inc. (de)
8 Feb 24
Other Events
12:00am
8-K
TTNP
Titan Pharmaceuticals, Inc. (de)
25 Jan 24
Other Events
4:33pm
8-K
pwuty oqh
18 Jan 24
Departure of Directors or Certain Officers
4:59pm
8-K
duei0hv
8 Jan 24
Amendments to Articles of Incorporation or Bylaws
5:13pm
8-K
m0x4lfn
28 Dec 23
Titan Pharmaceuticals Announces Reverse Stock Split and Ratio
4:30pm
8-K
o3cv89r tve1
15 Nov 23
Other Events
4:05pm
8-K
330e17w
16 Oct 23
Titan Pharmaceuticals Announces Appointment of Dato’ Seow Gim Shen and Brynner Chiam to the Company’s Board of Directors
5:08pm
8-K/A
6r4r7cwf491 8q74j
19 Sep 23
Entry into a Material Definitive Agreement
4:41pm
8-K
ghxkyyw1kw26 w20mq
18 Sep 23
Entry into a Material Definitive Agreement
4:45pm
8-K
3avu3qulw
8 Sep 23
Entry into a Material Definitive Agreement
5:30pm
8-K
l4yz9l49xr
30 Aug 23
Entry into a Material Definitive Agreement
4:28pm
8-K
pkgjdco
27 Jul 23
Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets
5:40pm
8-K
sx5hhf5 sb3hn9sr
7 Jul 23
Other Events
10:28am
8-K
7kll0qxq 1qvcj
29 Jun 23
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
phnrr13r6tmvcft6
6 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:23pm
8-K
uwuvufa3r3fcfsenzl
11 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:52pm
8-K
5agwj7l93q
22 Mar 23
Other Events
4:01pm